V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund Incyte Corp stake
total: 130
Dodge & Cox Stock Fund INCY trades
- Total transactions:
- 19
- New positions:
- 1
- Added:
- 8
- Reduced:
- 10
- Held since:
- 2019 Q3
- Held for:
- 27 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Dodge & Cox Stock Fund holds 8,281,428 Incyte Corp (INCY) shares with a market value of roughly $779.45M accounting for 0.68% of the overall portfolio. To date, the estimated cost basis is nearly $79.03 for "buy" trades and estimated average "sell" price is $72.12. Dodge & Cox Stock Fund first purchased INCY in 2019 Q3, initially acquiring about 2.00M shares. Since the initial investment in Incyte Corp (INCY), Dodge & Cox Stock Fund has made 18 more transactions.
When did Dodge & Cox Stock Fund buy Incyte Corp (INCY)?
Dodge & Cox Stock Fund first invested in Incyte Corp (INCY) in 2019 Q3 at the reported quarter-end price of $74.23 per share.
What's the cost basis of Dodge & Cox Stock Fund's INCY stake?
The estimated cost basis for Incyte Corp (INCY) stake is around $79.03 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $79.03
- Weighted AVG sell price:
- $72.12
Dodge & Cox Stock Fund's historical trades in Incyte Corp
19 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.68%
|
8,281,428
|
$94.12
|
$779,448,003
|
-7.86% (-705,986)
|
-0.06%
|
|
2025 Q4
|
0.74%
|
8,987,414
|
$98.77
|
$887,686,881
|
-4.73% (-446,014)
|
-0.04%
|
|
2025 Q2
|
0.55%
|
9,433,428
|
$68.10
|
$642,416,447
|
-2.80% (-272,000)
|
-0.02%
|
|
2024 Q4
|
0.60%
|
9,705,428
|
$69.07
|
$670,353,912
|
-0.10% (-9,700)
|
-0%
|
|
2024 Q1
|
0.51%
|
9,715,128
|
$56.97
|
$553,470,842
|
-4.16% (-421,500)
|
-0.02%
|
|
2023 Q4
|
0.63%
|
10,136,628
|
$62.79
|
$636,478,872
|
-1.65% (-170,266)
|
-0.01%
|
|
2023 Q3
|
0.64%
|
10,306,894
|
$57.77
|
$595,429,266
|
-14.44% (-1,739,106)
|
-0.11%
|
|
2023 Q2
|
0.81%
|
12,046,000
|
$62.25
|
$749,863,500
|
+0.36% (+43,700)
|
+0%
|
|
2022 Q4
|
1.09%
|
12,002,300
|
$80.32
|
$964,024,736
|
-1.78% (-217,400)
|
-0.02%
|
|
2022 Q3
|
1.03%
|
12,219,700
|
$66.64
|
$814,320,808
|
+0.20% (+24,700)
|
+0%
|
|
2022 Q2
|
1.09%
|
$75.97
|
+13.52% (+1,452,000)
|
|||
|
2022 Q1
|
0.86%
|
$79.42
|
+9.28% (+912,700)
|
|||
|
2021 Q3
|
0.74%
|
$68.78
|
+16.29% (+1,377,100)
|
|||
|
2021 Q2
|
0.80%
|
$84.13
|
+227.83% (+5,874,647)
|
|||
|
2021 Q1
|
0.26%
|
$81.27
|
+18.04% (+394,053)
|
|||
|
2020 Q4
|
0.27%
|
$86.98
|
-0.16% (-3,600)
|
|||
|
2020 Q2
|
0.38%
|
$103.97
|
-6.42% (-150,000)
|
|||
|
2020 Q1
|
0.33%
|
$73.23
|
+17.15% (+342,200)
|
|||
|
2019 Q3
|
0.21%
|
$74.23
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.